Abstract
Objectives: To treat patients with chronic discogenic low back pain with intradiscal steroid injections (IDSI) and observe clinical outcomes and complications. Methods: We studied 65 patients with chronic discogenic low back pain of more than 6 months' duration, who underwent IDSI. All subjects underwent magnetic resonance imaging to identify the degenerative discs, which had high-intensity zones at the posterior annulus and positive discographic examinations. We injected 1 ml of 1% xylocaine and 1 ml of 40 mg/ml triamcinolone acetonide mixture into the degenerative disc. All patients were monitored at 1, 3, 6, and 12 months postinjection. We used the Denis pain scale, Denis work scale, Roland-Morris scale, and finger-to-floor distance for clinical evaluation and all patients were monitored for at least 1 year. Results: Fifty-two patients (80%) displayed improvement 1 month after undergoing IDSI and 47 (72%) continued to feel satisfied 12 months after undergoing this procedure. No complications were encountered. Conclusion: IDSI appears to be a simple and safe treatment for chronic discogenic low back pain. Provided that the indication for IDSI is correct, clinical improvement can be expected.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call